UniProt ID | TXNIP_HUMAN | |
---|---|---|
UniProt AC | Q9H3M7 | |
Protein Name | Thioredoxin-interacting protein | |
Gene Name | TXNIP | |
Organism | Homo sapiens (Human). | |
Sequence Length | 391 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | May act as an oxidative stress mediator by inhibiting thioredoxin activity or by limiting its bioavailability. Interacts with COPS5 and restores COPS5-induced suppression of CDKN1B stability, blocking the COPS5-mediated translocation of CDKN1B from the nucleus to the cytoplasm. Functions as a transcriptional repressor, possibly by acting as a bridge molecule between transcription factors and corepressor complexes, and over-expression will induce G0/G1 cell cycle arrest. Required for the maturation of natural killer cells. Acts as a suppressor of tumor cell growth. Inhibits the proteasomal degradation of DDIT4, and thereby contributes to the inhibition of the mammalian target of rapamycin complex 1 (mTORC1).. | |
Protein Sequence | MVMFKKIKSFEVVFNDPEKVYGSGEKVAGRVIVEVCEVTRVKAVRILACGVAKVLWMQGSQQCKQTSEYLRYEDTLLLEDQPTGENEMVIMRPGNKYEYKFGFELPQGPLGTSFKGKYGCVDYWVKAFLDRPSQPTQETKKNFEVVDLVDVNTPDLMAPVSAKKEKKVSCMFIPDGRVSVSARIDRKGFCEGDEISIHADFENTCSRIVVPKAAIVARHTYLANGQTKVLTQKLSSVRGNHIISGTCASWRGKSLRVQKIRPSILGCNILRVEYSLLIYVSVPGSKKVILDLPLVIGSRSGLSSRTSSMASRTSSEMSWVDLNIPDTPEAPPCYMDVIPEDHRLESPTTPLLDDMDGSQDSPIFMYAPEFKFMPPPTYTEVDPCILNNNVQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
8 | Sumoylation | MVMFKKIKSFEVVFN CCCCEECCEEEEEEC | 58.95 | - | |
8 | Sumoylation | MVMFKKIKSFEVVFN CCCCEECCEEEEEEC | 58.95 | - | |
9 | Phosphorylation | VMFKKIKSFEVVFND CCCEECCEEEEEECC | 30.07 | 27499020 | |
19 | Sumoylation | VVFNDPEKVYGSGEK EEECCHHHHCCCCCE | 46.26 | - | |
19 | Ubiquitination | VVFNDPEKVYGSGEK EEECCHHHHCCCCCE | 46.26 | 29967540 | |
19 | Sumoylation | VVFNDPEKVYGSGEK EEECCHHHHCCCCCE | 46.26 | - | |
21 | Phosphorylation | FNDPEKVYGSGEKVA ECCHHHHCCCCCEEC | 19.35 | 23312004 | |
23 | Phosphorylation | DPEKVYGSGEKVAGR CHHHHCCCCCEECCE | 26.54 | 23312004 | |
26 | Ubiquitination | KVYGSGEKVAGRVIV HHCCCCCEECCEEEE | 40.69 | 23000965 | |
41 | Ubiquitination | EVCEVTRVKAVRILA EEEECCCCEEHHHHH | 3.22 | 23503661 | |
45 | Ubiquitination | VTRVKAVRILACGVA CCCCEEHHHHHHHHH | 24.06 | 23503661 | |
53 | Ubiquitination | ILACGVAKVLWMQGS HHHHHHHHHHHHCCC | 35.14 | - | |
60 | Ubiquitination | KVLWMQGSQQCKQTS HHHHHCCCHHHHHHH | 10.53 | 21890473 | |
60 | Phosphorylation | KVLWMQGSQQCKQTS HHHHHCCCHHHHHHH | 10.53 | - | |
60 | Ubiquitination | KVLWMQGSQQCKQTS HHHHHCCCHHHHHHH | 10.53 | 22817900 | |
62 | Ubiquitination | LWMQGSQQCKQTSEY HHHCCCHHHHHHHHH | 37.76 | 22817900 | |
64 | Ubiquitination | MQGSQQCKQTSEYLR HCCCHHHHHHHHHHC | 52.88 | - | |
85 | Ubiquitination | LEDQPTGENEMVIMR ECCCCCCCCEEEEEC | 53.12 | 29967540 | |
96 | Ubiquitination | VIMRPGNKYEYKFGF EEECCCCEEEEEEEE | 45.43 | 23503661 | |
100 | Sumoylation | PGNKYEYKFGFELPQ CCCEEEEEEEEECCC | 27.37 | - | |
100 | Sumoylation | PGNKYEYKFGFELPQ CCCEEEEEEEEECCC | 27.37 | - | |
100 | Ubiquitination | PGNKYEYKFGFELPQ CCCEEEEEEEEECCC | 27.37 | 23503661 | |
108 | Ubiquitination | FGFELPQGPLGTSFK EEEECCCCCCCCCCC | 19.91 | 32015554 | |
109 | Ubiquitination | GFELPQGPLGTSFKG EEECCCCCCCCCCCC | 23.52 | 23503661 | |
111 | Ubiquitination | ELPQGPLGTSFKGKY ECCCCCCCCCCCCCC | 23.58 | 23503661 | |
112 | Ubiquitination | LPQGPLGTSFKGKYG CCCCCCCCCCCCCCC | 38.38 | 23503661 | |
115 | Sumoylation | GPLGTSFKGKYGCVD CCCCCCCCCCCCCHH | 55.02 | - | |
115 | Ubiquitination | GPLGTSFKGKYGCVD CCCCCCCCCCCCCHH | 55.02 | 21906983 | |
115 | Sumoylation | GPLGTSFKGKYGCVD CCCCCCCCCCCCCHH | 55.02 | - | |
117 | Ubiquitination | LGTSFKGKYGCVDYW CCCCCCCCCCCHHHH | 38.77 | 22817900 | |
117 | Sumoylation | LGTSFKGKYGCVDYW CCCCCCCCCCCHHHH | 38.77 | - | |
117 | Sumoylation | LGTSFKGKYGCVDYW CCCCCCCCCCCHHHH | 38.77 | - | |
140 | Ubiquitination | SQPTQETKKNFEVVD CCCCHHHHCCEEEEE | 44.99 | 29967540 | |
140 | Sumoylation | SQPTQETKKNFEVVD CCCCHHHHCCEEEEE | 44.99 | - | |
140 | Sumoylation | SQPTQETKKNFEVVD CCCCHHHHCCEEEEE | 44.99 | - | |
141 | Ubiquitination | QPTQETKKNFEVVDL CCCHHHHCCEEEEEE | 74.43 | - | |
157 | Ubiquitination | DVNTPDLMAPVSAKK ECCCCCCCCCCCCCC | 5.30 | 21890473 | |
157 | Ubiquitination | DVNTPDLMAPVSAKK ECCCCCCCCCCCCCC | 5.30 | 21890473 | |
163 | Ubiquitination | LMAPVSAKKEKKVSC CCCCCCCCCCCCEEE | 54.69 | 32015554 | |
163 | Sumoylation | LMAPVSAKKEKKVSC CCCCCCCCCCCCEEE | 54.69 | - | |
163 | Sumoylation | LMAPVSAKKEKKVSC CCCCCCCCCCCCEEE | 54.69 | - | |
164 | Ubiquitination | MAPVSAKKEKKVSCM CCCCCCCCCCCEEEE | 74.59 | 23503661 | |
166 | Ubiquitination | PVSAKKEKKVSCMFI CCCCCCCCCEEEEEE | 68.31 | 23503661 | |
167 | Ubiquitination | VSAKKEKKVSCMFIP CCCCCCCCEEEEEEC | 40.24 | 23503661 | |
167 | Sumoylation | VSAKKEKKVSCMFIP CCCCCCCCEEEEEEC | 40.24 | - | |
167 | Sumoylation | VSAKKEKKVSCMFIP CCCCCCCCEEEEEEC | 40.24 | - | |
173 | Ubiquitination | KKVSCMFIPDGRVSV CCEEEEEECCCCEEE | 0.90 | 22817900 | |
173 | Ubiquitination | KKVSCMFIPDGRVSV CCEEEEEECCCCEEE | 0.90 | 21890473 | |
178 | Ubiquitination | MFIPDGRVSVSARID EEECCCCEEEEEEEC | 8.95 | 21890473 | |
178 | Ubiquitination | MFIPDGRVSVSARID EEECCCCEEEEEEEC | 8.95 | 22817900 | |
187 | Ubiquitination | VSARIDRKGFCEGDE EEEEECCCCCCCCCE | 53.22 | - | |
206 | Phosphorylation | ADFENTCSRIVVPKA ECCCCCCCCEEECHH | 24.01 | 24719451 | |
212 | Sumoylation | CSRIVVPKAAIVARH CCCEEECHHHEEEEE | 38.55 | - | |
212 | Sumoylation | CSRIVVPKAAIVARH CCCEEECHHHEEEEE | 38.55 | - | |
212 | Ubiquitination | CSRIVVPKAAIVARH CCCEEECHHHEEEEE | 38.55 | 22817900 | |
228 | Sumoylation | YLANGQTKVLTQKLS EECCCCEEEEEECHH | 27.62 | - | |
228 | Sumoylation | YLANGQTKVLTQKLS EECCCCEEEEEECHH | 27.62 | - | |
228 | Ubiquitination | YLANGQTKVLTQKLS EECCCCEEEEEECHH | 27.62 | 21906983 | |
231 | Ubiquitination | NGQTKVLTQKLSSVR CCCEEEEEECHHHCC | 27.01 | 22817900 | |
232 | Ubiquitination | GQTKVLTQKLSSVRG CCEEEEEECHHHCCC | 40.30 | 21890473 | |
232 | Ubiquitination | GQTKVLTQKLSSVRG CCEEEEEECHHHCCC | 40.30 | 21890473 | |
233 | Ubiquitination | QTKVLTQKLSSVRGN CEEEEEECHHHCCCC | 45.13 | 22817900 | |
233 | Sumoylation | QTKVLTQKLSSVRGN CEEEEEECHHHCCCC | 45.13 | - | |
233 | Sumoylation | QTKVLTQKLSSVRGN CEEEEEECHHHCCCC | 45.13 | - | |
233 | Malonylation | QTKVLTQKLSSVRGN CEEEEEECHHHCCCC | 45.13 | 26320211 | |
235 | Phosphorylation | KVLTQKLSSVRGNHI EEEEECHHHCCCCEE | 33.55 | 24719451 | |
249 | Phosphorylation | IISGTCASWRGKSLR EEECCCCCCCCCCCE | 21.32 | 28857561 | |
259 | Ubiquitination | GKSLRVQKIRPSILG CCCCEEEECCHHHHC | 37.51 | - | |
286 | Ubiquitination | YVSVPGSKKVILDLP EEECCCCCEEEEECC | 57.90 | 22817900 | |
287 | Sumoylation | VSVPGSKKVILDLPL EECCCCCEEEEECCE | 35.88 | - | |
287 | Ubiquitination | VSVPGSKKVILDLPL EECCCCCEEEEECCE | 35.88 | 21906983 | |
287 | Sumoylation | VSVPGSKKVILDLPL EECCCCCEEEEECCE | 35.88 | - | |
300 | Phosphorylation | PLVIGSRSGLSSRTS CEEEECCCCCCHHCC | 45.87 | 23090842 | |
303 | Phosphorylation | IGSRSGLSSRTSSMA EECCCCCCHHCCHHC | 22.69 | 23090842 | |
304 | Phosphorylation | GSRSGLSSRTSSMAS ECCCCCCHHCCHHCC | 44.62 | 23090842 | |
306 | Phosphorylation | RSGLSSRTSSMASRT CCCCCHHCCHHCCCC | 27.40 | 23090842 | |
307 | Phosphorylation | SGLSSRTSSMASRTS CCCCHHCCHHCCCCC | 19.60 | 23090842 | |
308 | Phosphorylation | GLSSRTSSMASRTSS CCCHHCCHHCCCCCC | 20.11 | 23090842 | |
311 | Phosphorylation | SRTSSMASRTSSEMS HHCCHHCCCCCCCCC | 27.70 | 23090842 | |
313 | Phosphorylation | TSSMASRTSSEMSWV CCHHCCCCCCCCCCC | 33.82 | 27642862 | |
314 | Phosphorylation | SSMASRTSSEMSWVD CHHCCCCCCCCCCCC | 24.16 | 26356563 | |
315 | Phosphorylation | SMASRTSSEMSWVDL HHCCCCCCCCCCCCC | 36.38 | 22210691 | |
318 | Phosphorylation | SRTSSEMSWVDLNIP CCCCCCCCCCCCCCC | 21.64 | 26356563 | |
327 | Phosphorylation | VDLNIPDTPEAPPCY CCCCCCCCCCCCCCE | 20.06 | 27642862 | |
334 | Phosphorylation | TPEAPPCYMDVIPED CCCCCCCEEECCCCC | 11.34 | 27642862 | |
346 | Phosphorylation | PEDHRLESPTTPLLD CCCCCCCCCCCCCCC | 31.94 | 28450419 | |
348 | Phosphorylation | DHRLESPTTPLLDDM CCCCCCCCCCCCCCC | 50.77 | 28450419 | |
349 | Phosphorylation | HRLESPTTPLLDDMD CCCCCCCCCCCCCCC | 18.47 | 28102081 | |
358 | Phosphorylation | LLDDMDGSQDSPIFM CCCCCCCCCCCCEEE | 26.92 | 28102081 | |
361 | Phosphorylation | DMDGSQDSPIFMYAP CCCCCCCCCEEEECC | 16.56 | 20068034 | |
366 | Phosphorylation | QDSPIFMYAPEFKFM CCCCEEEECCCCCCC | 14.30 | 28450419 | |
377 | Phosphorylation | FKFMPPPTYTEVDPC CCCCCCCCCCCCCCC | 49.18 | 21945579 | |
378 | Phosphorylation | KFMPPPTYTEVDPCI CCCCCCCCCCCCCCC | 13.48 | 21945579 | |
379 | Phosphorylation | FMPPPTYTEVDPCIL CCCCCCCCCCCCCCC | 31.82 | 21945579 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
308 | S | Phosphorylation | Kinase | PRKAA1 | Q13131 | GPS |
349 | T | Phosphorylation | Kinase | ERK2 | P28482 | PSP |
361 | S | Phosphorylation | Kinase | P38A | Q16539 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | ITCH | Q96J02 | PMID:20068034 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TXNIP_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TXNIP_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-349 AND SER-361, ANDMASS SPECTROMETRY. | |
Ubiquitylation | |
Reference | PubMed |
"Quantitative analysis of global ubiquitination in HeLa cells by massspectrometry."; Meierhofer D., Wang X., Huang L., Kaiser P.; J. Proteome Res. 7:4566-4576(2008). Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-212, AND MASSSPECTROMETRY. |